DK2707476T3 - Lactobacillus fermentum CECTA 7472 stamme med probiotiske egenskaber - Google Patents
Lactobacillus fermentum CECTA 7472 stamme med probiotiske egenskaber Download PDFInfo
- Publication number
- DK2707476T3 DK2707476T3 DK12718244.2T DK12718244T DK2707476T3 DK 2707476 T3 DK2707476 T3 DK 2707476T3 DK 12718244 T DK12718244 T DK 12718244T DK 2707476 T3 DK2707476 T3 DK 2707476T3
- Authority
- DK
- Denmark
- Prior art keywords
- strain
- cect
- fermentum
- milk
- edible
- Prior art date
Links
- 241000186840 Lactobacillus fermentum Species 0.000 title claims description 91
- 230000000529 probiotic effect Effects 0.000 title claims description 32
- 229940012969 lactobacillus fermentum Drugs 0.000 title claims description 24
- 239000000047 product Substances 0.000 claims description 52
- 239000006041 probiotic Substances 0.000 claims description 36
- 235000018291 probiotics Nutrition 0.000 claims description 36
- 241000607447 Yersinia enterocolitica Species 0.000 claims description 24
- 235000013305 food Nutrition 0.000 claims description 24
- 230000036541 health Effects 0.000 claims description 24
- 235000013618 yogurt Nutrition 0.000 claims description 23
- 229940098232 yersinia enterocolitica Drugs 0.000 claims description 20
- 241000186779 Listeria monocytogenes Species 0.000 claims description 18
- 235000013336 milk Nutrition 0.000 claims description 16
- 210000004080 milk Anatomy 0.000 claims description 16
- 244000052769 pathogen Species 0.000 claims description 16
- 239000008267 milk Substances 0.000 claims description 15
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 11
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 235000016709 nutrition Nutrition 0.000 claims description 8
- 230000001717 pathogenic effect Effects 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000013350 formula milk Nutrition 0.000 claims description 6
- 230000001737 promoting effect Effects 0.000 claims description 5
- 235000013351 cheese Nutrition 0.000 claims description 4
- 235000015872 dietary supplement Nutrition 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 2
- 235000013339 cereals Nutrition 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- 235000015243 ice cream Nutrition 0.000 claims description 2
- 235000013372 meat Nutrition 0.000 claims description 2
- 239000005862 Whey Substances 0.000 claims 1
- 102000007544 Whey Proteins Human genes 0.000 claims 1
- 108010046377 Whey Proteins Proteins 0.000 claims 1
- 235000015218 chewing gum Nutrition 0.000 claims 1
- 229940112822 chewing gum Drugs 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 235000021262 sour milk Nutrition 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 241001465754 Metazoa Species 0.000 description 28
- 208000015181 infectious disease Diseases 0.000 description 28
- 241000894006 Bacteria Species 0.000 description 24
- 230000000694 effects Effects 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 19
- 235000020251 goat milk Nutrition 0.000 description 19
- 238000012360 testing method Methods 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 238000000855 fermentation Methods 0.000 description 14
- 230000004151 fermentation Effects 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 201000010099 disease Diseases 0.000 description 13
- 230000002496 gastric effect Effects 0.000 description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- 230000008901 benefit Effects 0.000 description 11
- 235000013365 dairy product Nutrition 0.000 description 11
- 238000000338 in vitro Methods 0.000 description 11
- 241000186660 Lactobacillus Species 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 10
- 244000005700 microbiome Species 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 241000282414 Homo sapiens Species 0.000 description 8
- 239000002158 endotoxin Substances 0.000 description 8
- 238000001727 in vivo Methods 0.000 description 8
- 229940039696 lactobacillus Drugs 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 7
- 229920006008 lipopolysaccharide Polymers 0.000 description 7
- 244000144977 poultry Species 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- 108010074328 Interferon-gamma Proteins 0.000 description 6
- 241000607734 Yersinia <bacteria> Species 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000003833 bile salt Substances 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 230000003834 intracellular effect Effects 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 6
- 239000003226 mitogen Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 229940093761 bile salts Drugs 0.000 description 5
- 230000005757 colony formation Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 210000003608 fece Anatomy 0.000 description 5
- 235000013376 functional food Nutrition 0.000 description 5
- 230000002519 immonomodulatory effect Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 108010062580 Concanavalin A Proteins 0.000 description 4
- 208000018522 Gastrointestinal disease Diseases 0.000 description 4
- 102000003814 Interleukin-10 Human genes 0.000 description 4
- 108090000174 Interleukin-10 Proteins 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 241000194020 Streptococcus thermophilus Species 0.000 description 4
- 210000001744 T-lymphocyte Anatomy 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 210000004211 gastric acid Anatomy 0.000 description 4
- 229940076144 interleukin-10 Drugs 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000000770 proinflammatory effect Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 210000004988 splenocyte Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 241000283705 Capra hircus Species 0.000 description 3
- 208000011231 Crohn disease Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 206010061598 Immunodeficiency Diseases 0.000 description 3
- 102100037850 Interferon gamma Human genes 0.000 description 3
- 102000008070 Interferon-gamma Human genes 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 206010048249 Yersinia infections Diseases 0.000 description 3
- 230000009102 absorption Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 235000020247 cow milk Nutrition 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 210000001842 enterocyte Anatomy 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 229940044627 gamma-interferon Drugs 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 244000005709 gut microbiome Species 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 230000007358 intestinal barrier function Effects 0.000 description 3
- 208000028774 intestinal disease Diseases 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 230000003334 potential effect Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 108010062877 Bacteriocins Proteins 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010024641 Listeriosis Diseases 0.000 description 2
- 208000008771 Lymphadenopathy Diseases 0.000 description 2
- 201000009906 Meningitis Diseases 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 235000014048 cultured milk product Nutrition 0.000 description 2
- 230000016396 cytokine production Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000021001 fermented dairy product Nutrition 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000019138 food restriction Nutrition 0.000 description 2
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 2
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 238000000099 in vitro assay Methods 0.000 description 2
- 238000005462 in vivo assay Methods 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 210000005027 intestinal barrier Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 208000018555 lymphatic system disease Diseases 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000006872 mrs medium Substances 0.000 description 2
- 210000003550 mucous cell Anatomy 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 238000000879 optical micrograph Methods 0.000 description 2
- 230000009984 peri-natal effect Effects 0.000 description 2
- 210000001986 peyer's patch Anatomy 0.000 description 2
- 238000012809 post-inoculation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 230000010490 psychological well-being Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000003393 splenic effect Effects 0.000 description 2
- 239000008174 sterile solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- CFYIUBWVKZQDOG-UHFFFAOYSA-N 4-[[2-[[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-4-oxobutanoic acid Chemical compound C=1C=C([N+]([O-])=O)C=CC=1NC(=O)C(NC(=O)CNC(=O)CNC(=O)CCC(=O)O)CC1=CC=CC=C1 CFYIUBWVKZQDOG-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 206010015226 Erythema nodosum Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010017943 Gastrointestinal conditions Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 208000033981 Hereditary haemochromatosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 102000004890 Interleukin-8 Human genes 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 206010024652 Liver abscess Diseases 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000010227 enterocolitis Diseases 0.000 description 1
- 208000037902 enteropathy Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000021472 generally recognized as safe Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000010453 mesenteric lymphadenitis Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 201000005789 splenic abscess Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 208000012267 terminal ileitis Diseases 0.000 description 1
- 125000003831 tetrazolyl group Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002723 toxicity assay Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000000207 volumetry Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Claims (10)
1. Isoleret stamme af Lactobacillus fermentum deponeret hos Coleccion Espafiola de Cultivos Tipo (CECT) under deponeringsnummeret CECT 7472.
2. Ren bakteriekultur, som omfatter stammen ifølge krav 1.
3. Spiseligt produkt, som omfatter en ernæringsmæssig effektiv mængde af stammen ifølge krav 1 sammen med passende mængder af andre spiselige ingredienser.
4. Spiseligt produkt ifølge krav 3, som er valgt fra gruppen bestående af et mælkeprodukt, yoghurt, valle, ost, syrnet mælk, mælkepulver, mælkebaseret fermenteret produkt, kødbaseret fermenteret produkt, flødeis, kornbaseret fermenteret produkt, drikkevare, mel, tyggegummi, slik, sødet madvare, kæledyrsfoder, kosttilskud, funktionelt næringsmiddel, klinisk ernæringsformel, ernæringskomplement, formel til ældre mennesker og en spædbørnsformel.
5. Fremgangsmåde til tilberedning af et spiseligt produkt ifølge ethvert af krav 3-4, omfattende tilførsel af stammen ifølge krav 1 eller en kultur ifølge krav 2 til det spiselige produkt.
6. Stammen af Lactobacillus fermentum CECT 7472 ifølge krav 1 til anvendelse som probiotisk middel.
7. Stammen af Lactobacillus fermentum CECT 7472 ifølge krav 1 til anvendelse som sundhedsfremmende middel i mave-tarmkanalen.
8. Stamme ifølge krav 7, som sundhedsfremmende middel i mave-tarmkanalen, når kanalen er invaderet af en patogen valgt fra gruppen bestående af Yersinia enterocolitica og Listeria monocytogenes.
9. Spiseligt produkt ifølge ethvert af krav 3-4 som sundhedsfremmende middel i mave-tarmkanalen.
10. Spiseligt produkt ifølge krav 9, som fremmer sundheden i mave-tarmkanalen, når denne er invaderet af et patogen valgt fra gruppen bestående af Yersinia enterocolitica og Listeria monocytogenes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11382132A EP2520644A1 (en) | 2011-05-06 | 2011-05-06 | Lactobacillus fermentum CECT 7472 strain with probiotic properties |
| PCT/EP2012/058214 WO2012152680A1 (en) | 2011-05-06 | 2012-05-04 | Lactobacillus fermentum cect 7472 strain with probiotic properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2707476T3 true DK2707476T3 (da) | 2015-09-28 |
Family
ID=44558299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12718244.2T DK2707476T3 (da) | 2011-05-06 | 2012-05-04 | Lactobacillus fermentum CECTA 7472 stamme med probiotiske egenskaber |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP2520644A1 (da) |
| DK (1) | DK2707476T3 (da) |
| ES (1) | ES2549541T3 (da) |
| HR (1) | HRP20151074T1 (da) |
| HU (1) | HUE027285T2 (da) |
| PL (1) | PL2707476T3 (da) |
| PT (1) | PT2707476E (da) |
| WO (1) | WO2012152680A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104531549B (zh) * | 2014-05-28 | 2018-08-10 | 西南大学 | 一种可调节肠道运动、预防便秘的发酵乳杆菌Lactobacillus fermentum strain Zhao及其用途 |
| CN104381440B (zh) * | 2014-07-17 | 2017-07-11 | 西南民族大学 | 发酵乳杆菌Lactobacillus fermentum strain Lee工作发酵剂制品及其预防便秘保健用途 |
| CN104430847B (zh) * | 2014-07-17 | 2017-07-11 | 西南民族大学 | 发酵乳杆菌Lactobacillus fermentum Lee工作发酵剂制品及其预防便秘保健用途 |
| KR102024883B1 (ko) * | 2017-11-24 | 2019-09-24 | 주식회사 고바이오랩 | 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도 |
| CN108464509B (zh) * | 2018-03-12 | 2021-07-13 | 浙江亲水园生物科技有限公司 | 新型发酵乳酸杆菌在食品领域中的应用 |
-
2011
- 2011-05-06 EP EP11382132A patent/EP2520644A1/en not_active Withdrawn
-
2012
- 2012-05-04 DK DK12718244.2T patent/DK2707476T3/da active
- 2012-05-04 ES ES12718244.2T patent/ES2549541T3/es active Active
- 2012-05-04 PT PT127182442T patent/PT2707476E/pt unknown
- 2012-05-04 WO PCT/EP2012/058214 patent/WO2012152680A1/en active Application Filing
- 2012-05-04 EP EP12718244.2A patent/EP2707476B1/en not_active Not-in-force
- 2012-05-04 PL PL12718244T patent/PL2707476T3/pl unknown
- 2012-05-04 HU HUE12718244A patent/HUE027285T2/en unknown
-
2015
- 2015-10-09 HR HRP20151074TT patent/HRP20151074T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2549541T3 (es) | 2015-10-29 |
| EP2520644A1 (en) | 2012-11-07 |
| EP2707476A1 (en) | 2014-03-19 |
| PT2707476E (pt) | 2015-10-20 |
| WO2012152680A1 (en) | 2012-11-15 |
| PL2707476T3 (pl) | 2016-07-29 |
| HRP20151074T1 (hr) | 2016-04-22 |
| HUE027285T2 (en) | 2016-09-28 |
| EP2707476B1 (en) | 2015-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11759486B2 (en) | Lactobacillus plantarum and composition comprising same | |
| Shokryazdan et al. | Probiotics: from isolation to application | |
| Sharma et al. | Identification and probiotic potential of lactic acid bacteria from camel milk | |
| JP5710250B2 (ja) | 哺乳類乳汁微生物、それらを含有する組成物および乳腺炎の治療のためのそれらの使用 | |
| KR102084825B1 (ko) | 유아의 과도한 울음용 프로바이오틱 | |
| DK2707476T3 (da) | Lactobacillus fermentum CECTA 7472 stamme med probiotiske egenskaber | |
| Viaşu-Bolocan et al. | Probiotics and their immunomodulatory potential | |
| Nigam | Probiotics as functional foods in enhancing gut immunity | |
| Sako et al. | The world’s oldest probiotic: perspectives for health claims | |
| Boyiri | Probiotic potential of bacterial isolates from ‘amabere amaruranu’cultured milk | |
| Sharma et al. | Characterization of Probiotic Cultures from Traditional Foods of Himachal Pradesh and their Efficacy against Colonization by Cronobacter Sakazakii in Caenorhabditis Elegans Model System | |
| ul Hasnat | Exploring Probiotic Bacteria from Different Food Sources. | |
| Kamber | Modulating Akkermansia muciniphila by probiotics for obesity management | |
| Soyer et al. | Determination of potential probiotic properties of lactic acid bacteria isolated from colostrum milk | |
| Microflora | Oral Communications | |
| Cozzolino | Adhesion properties to human cell lines and other features of probiotic interest in Lactobacillus rhamnosus and Akkermansia muciniphila strains | |
| Mandal | Study of Lactobacillus Isolates from Human Sources with regard to Their Beneficial Physiological Attributes | |
| GUIDESI | INTEGRATED APPROACH TO THE SELECTION OF NEW PROBIOTICS FOR HUMAN APPLICATION | |
| ES2367518T3 (es) | Lactobacilli probióticos felinos. | |
| Shulpekova | The normal composition of the intestinal microflora and its importance for the body. Normal microflora of the animal body Microflora of the respiratory system |